How to avoid CIN: Guidelines from the European Society of Urogenital Radiology

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 1, 2005, Pages

  Thomsen, Henrik S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Contrast media; Dialysis; Metformin; Nephrotoxicity; Renal adverse reactions

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR DERIVATIVE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; FUROSEMIDE; GADOLINIUM; IODINATED CONTRAST MEDIUM; IONIC CONTRAST MEDIUM; LOOP DIURETIC AGENT; MANNITOL; METFORMIN; NITRENDIPINE; SODIUM CHLORIDE; THEOPHYLLINE;

ANURIA; BLOOD VISCOSITY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REGIMEN; HEART ARRHYTHMIA; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYDRATION; HYPOTENSION; KIDNEY DISEASE; MEDICAL SOCIETY; META ANALYSIS; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOLALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE DRUG DOSE;

CONTRAST MEDIA; EUROPE; FEMALE UROGENITAL DISEASES; HUMANS; KIDNEY DISEASES; MALE UROGENITAL DISEASES; PRACTICE GUIDELINES; RADIOLOGY; SOCIETIES, MEDICAL;

EID: 14944346029     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1070     Document Type: Review

References (38)

1. Morcos SK, Thomsen HS, Webb JAW and members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602-1613
2. Morcos SK, Thomsen HS, Webb JAW and members of the Contrast Media Safety Committee of European Society of Urogenital Radiology. Dialysis and contrast media. Eur Radiol 2002; 12: 3026-1629
3. Thomsen HS, Almén T, Morcos SK and members of the Contrast Media Safety Committee of European Society of Urogenital Radiology. Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 2002; 12: 2600-2605
4. Thomsen HS, Morcos SK and members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Contrast media and metformin. Guidelines to diminish the risk of lactic acidosis in non-insulin dependent diabetics after administration of contrast media. Eur Radiol 1999; 9: 738-740
5. Rudnik MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254-261
6. Choyke PL, Cady K, DePollar SL, Austin H. Determination of serum creatinine prior to iodinated contrast media: is it needed in all patients? Tech Urol 1998; 4: 65-69
7. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 2000; 216: 481-484
8. Olsen JC, Salomon B. Utility of the creatinine prior to intravenous contrast studies in the emergency department. J Emerg Med 1996; 14: 543-546
9. Thomsen HS. Contrast nephropathy. In: Thomsen HS, Muller RN, Mattrey RF, eds. Trends in Contrast Media. Springer Verlag, Berlin: 1999; 103-116
10. Morcos SK. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 2004; 59: 381-389
11. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
12. Allaqaband S, Tumuluri R, Malik AM et al. Prospective randomized study of N-acetylcysteine, fenoldopam and saline for prevention of radiocontrast-induced nephropathy. Catheterization Cardiovasc Intervent 2002; 57: 279-283
13. Mueller C, Burkle G, Buerkle HJ et al. Prevention of contrast media-associated nephropathy. Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
14. Trivedi HS, Moore H, Nasr S et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: c29-c34
15. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 1989; 4: 1030-1036
16. Carraro M, Mancini W, Aretro et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 1996; 11: 444-448
17. Weisberg L, Kurnik PB, Kurnik RC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-265
18. Kini AS, Mitre CA, Kim M et al. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheterization Cardiovasc Intervent 2002; 55: 169-173
19. Stone GW, McCullough PA, Tumlin JA et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy. A randomized controlled trial. J Am Med Assoc 2003; 290: 2284-2291.
20. Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999; 353: 133-138
21. Wang A, Holcslaw T, Bashore TM et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675-1680
22. Haylor JL, Morcos SK. Endothelin antagonism and contrast nephropathy. Kidney Int 2000; 58: 2239
23. Huber W, Ilgman K, Page M et al. Effect of theophylline on contrast material-induced nephropathy on patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 2002; 223: 772-779
24. Erley CM, Duda SH, Rehfuss D et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999; 14: 1146-1149
25. Tepel M, Giet MVD, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184
26. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89: 356-358
27. Kay J, Chow WH, Chan TM et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. A randomized controlled trial. J Am Med Assoc 2003; 289: 553-558
28. Durham JD, Caputo C, Dokko J et al. A randomized trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62: 2202-2207
29. Birck R, Krzossok S, Markowetz F et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603
30. Fishbane S, Durham JH, Marzo K, Rudnick M. N Acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251-260
31. Higgins JPT, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analysis. Br Med J 2003; 327: 557-560
32. Dehnarts T, Keller E, Gondolf K et al. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 1998; 13: 358-362
33. Vogt B, Ferrari P, Schonholzer C et al. Pre-emptive haemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
34. Frank H, Werner D, Lorusso V et al. Simultaneous haemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176-182
35. Huber W, Jeschke B, Kreymann B et al. Haemodialysis of the prevention of contrast-induced nephropathy. Outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Invest Radiol 2002; 37: 471-481
36. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by haemofiltration. N Engl J Med 2003; 349: 1333-1340
37. Sam II AD, Morasch MD, Collins J et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003; 38: 313-318
38. Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol in press.